Portland, OR — (PRESS RELEASE JET) — 09/15/2017 — Flunarizine hydrochloride is a calcium antagonist drug that acts by reducing or preventing migraine headaches. This drug is used to treat dizziness and vertigo.Growth in the prevalence of migraine, increasing consumption of junk food, smoking & drinking, and hectic & stressful lifestyle that leads to migraines drive the flunarizine hydrochloride market growth. Furthermore, increasing awareness of healthcare among the population and low cost of flunarizine hydrochloride are anticipated to boost the market growth. However, adverse effects, presence of substitutes such as amlodipine, and stringent government regulations related to the safety & efficacy of flunarizine hydrochloride hinder the market growth.
Continue to Report Description and Full ToC: https://www.alliedmarketresearch.com/request-toc-and-sample/3993
The market is segmented on the basis of application, drug formulation, and region. Based on application, the market is categorized into migraine and vertigo. By drug formulation, it is bifurcated into tablets and capsules. The geographical breakdown of each of the aforesaid segments has been covered for North America, Europe, Asia-Pacific, and LAMEA.
Place Purchase Order for this Report @:https://www.alliedmarketresearch.com/purchase-enquiry/3993
– The study provides an in-depth analysis of the global flunarizine hydrochloride market with current trends and future estimations to elucidate investment pockets.
– Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
– The report provides a quantitative analysis to help stakeholders to capitalize on prevailing market opportunities.
– Extensive analysis of different segments helps understand various products of the market.
– Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.
Flunarizine Hydrochloride Market
By Drug Formulation:
Some Major key players in the market ohnson & Johnson, Cipla Limited, Torrent Pharmaceuticals Ltd,
Aa Pharma Inc, Karnataka Antibiotics & Pharmaceuticals Ltd, Cadila Pharmaceuticals Ltd, OrchidChemicals &Pharmaceuticals Ltd, Fdc Ltd, Alkem Laboratories Ltd and Intas Pharmaceuticals Ltd
if You have a query, connect to our Analyst: https://www.alliedmarketresearch.com/connect-to-analyst/3993
“Early buyers will receive 20% customization on this report”
Powered by WPeMatico